Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Urothelial Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG™) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - Wichita Falls

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Texas Oncology - Denton

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Denton

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor Therapy

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number: 19018

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Denton

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

(C3441020) A PHASE 2, NON-RANDOMIZED, OPEN LABEL, SINGLE ARM, MULTI-CENTER STUDY OF TALAZOPARIB FOR NEOADJUVANT TREATMENT OF GERMLINE BRCA1/2 MUTATION PATIENTS WITH EARLY TRIPLE-NEGATIVE BREAST CANCER

  • Details

ClinicalTrials.gov ID: NCT03499353
Diagnosis Type: NA
USOR Number: 18042

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

GI Stromal Tumor (GIST)

Clinical Trial at: Texas Oncology - Denton

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

  • Details

ClinicalTrials.gov ID: NCT03465722
Diagnosis Type: NA
USOR Number: 18016

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Denton

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Denton

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Denton

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG™) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

SYD985.002: A multi-centre, open-label, randomized clinical trial comparing the efficacy and safety of the antibody-drug conjugate SYD985 to physician's choice in patients with HER2-positive unresectable locally advanced or metastatic breast cancer

  • Details

ClinicalTrials.gov ID: NCT03262935
Diagnosis Type: NA
USOR Number: 17027

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Texas Oncology - Denton

A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy (POD1UM-202)

  • Details

ClinicalTrials.gov ID: NCT03597295
Diagnosis Type: NA
USOR Number: 18134

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Pages